Compare Stocks

→ The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRON Cronos Group	$2.48 +0.4%	$2.35	$1.64 ▼ $2.99	$947.39M	1.17	2.93 million shs	2.52 million shs
STDAF STADA Arzneimittel Aktiengesellschaft	$110.42	$110.42	$75.15 ▼ $115.00	$6.88B	0.38	180 shs	N/A
TLRY Tilray	$1.84	$1.95	$1.50 ▼ $3.40	$1.42B	2.36	29.24 million shs	17.87 million shs

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRON Cronos Group	+4.66%	+1.23%	-5.36%	+22.89%	+37.22%
STDAF STADA Arzneimittel Aktiengesellschaft	0.00%	0.00%	0.00%	0.00%	0.00%
TLRY Tilray	+6.98%	+0.55%	-20.35%	-6.60%	-21.70%

The A.I. story nobody is telling you (Read ASAP) (Ad)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CRON Cronos Group	1.7202 of 5 stars	2.2	5.0	0.0	0.0	3.2	0.0	1.3
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	1.422 of 5 stars	3.1	2.0	0.0	0.0	2.4	0.0	1.3

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRON Cronos Group	2.33	Hold	$2.83	14.25% Upside
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A
TLRY Tilray	2.25	Hold	$2.71	47.19% Upside

Current Analyst Ratings

Latest STDAF, CRON, and TLRY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/10/2024	TLRY Tilray	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	$4.25 ➝ $4.00
4/10/2024	TLRY Tilray	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$2.25 ➝ $2.00
4/8/2024	CRON Cronos Group	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$2.00 ➝ $2.50
4/5/2024	TLRY Tilray	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral	$2.25 ➝ $2.75

(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRON Cronos Group	$87.24M	10.86	N/A	N/A	$2.87 per share	0.86
STDAF STADA Arzneimittel Aktiengesellschaft	$3.84B	1.79	$11.12 per share	9.93	$23.11 per share	4.78
TLRY Tilray	$627.12M	2.27	$0.00 per share	1,895.02	$4.32 per share	0.43

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRON Cronos Group	-$73.96M	-$0.19	N/A	82.67	N/A	-84.15%	-3.99%	-3.87%	5/14/2024 (Estimated)
STDAF STADA Arzneimittel Aktiengesellschaft	$292.15M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	-$1.45B	-$0.44	N/A	N/A	N/A	-43.98%	-2.68%	-2.09%	7/24/2024 (Estimated)

Latest STDAF, CRON, and TLRY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/29/2024	Q4 2023	CRON Cronos Group	N/A	-$0.05	-$0.05	$0.02	$25.15 million	$23.92 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRON Cronos Group	N/A	N/A	N/A	N/A	N/A
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRON Cronos Group	N/A	22.54	21.81
STDAF STADA Arzneimittel Aktiengesellschaft	2.23	1.54	0.99
TLRY Tilray	0.11	1.92	1.18

Ownership

Institutional Ownership

Company	Institutional Ownership
CRON Cronos Group	8.71%
STDAF STADA Arzneimittel Aktiengesellschaft	N/A
TLRY Tilray	9.35%

Insider Ownership

Company	Insider Ownership
CRON Cronos Group	1.96%
STDAF STADA Arzneimittel Aktiengesellschaft	N/A
TLRY Tilray	0.68%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CRON Cronos Group	356	382.01 million	374.52 million	Optionable
STDAF STADA Arzneimittel Aktiengesellschaft	12,500	62.34 million	N/A	Not Optionable
TLRY Tilray	1,600	774.03 million	768.77 million	Optionable

STDAF, CRON, and TLRY Headlines

Source	Headline
	Tilray (NASDAQ:TLRY) Trading Down 2.4% marketbeat.com - April 24 at 5:18 PM
	Top Canadian Marijuana Stocks To Invest In For Big Gains marijuanastocks.com - April 24 at 10:13 AM
	Cashing in on Cannabis: Why These 3 Weed Stocks Are Primed to Pop investorplace.com - April 24 at 9:00 AM
	3 Reasons Tilray Brands Investors Shouldn't Assume U.S. Marijuana Legalization Would Fix the Stock's Problems fool.com - April 24 at 6:45 AM
	Tilray (NASDAQ:TLRY) Shares Up 3.8% marketbeat.com - April 23 at 3:20 PM
	Tilray (NASDAQ:TLRY) Stock Price Down 3.2% marketbeat.com - April 22 at 2:53 PM
	Tilray (NASDAQ:TLRY) Shares Down 0.3% americanbankingnews.com - April 21 at 5:12 AM
	Tilray (NASDAQ:TLRY) Stock Price Up 3.8% marketbeat.com - April 18 at 3:41 PM
	Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation finance.yahoo.com - April 18 at 9:57 AM
	Montauk Brewing's Project 4:20 IPA Returns to Support Surfrider Foundation globenewswire.com - April 18 at 8:00 AM
	Latest News for Tilray Brands Stock (NASDAQ:TLRY) benzinga.com - April 18 at 4:56 AM
	Tilray (NASDAQ:TLRY) Trading Down 4.9% marketbeat.com - April 17 at 1:11 PM
	The Best Cannabis Stock to Invest $1,000 in Right Now fool.com - April 17 at 7:45 AM
	Tilray Brands Lights Up 420 With Music Festivals and Celebrations Across The Country finance.yahoo.com - April 17 at 7:32 AM
	What's Going On With Marijuana Grower Tilray's Stock? msn.com - April 16 at 4:10 PM
	Tilray (NASDAQ:TLRY) Trading Up 2% marketbeat.com - April 16 at 2:58 PM
	April 2024's Hot Picks: Top Canadian Cannabis Stocks To Watch Now marijuanastocks.com - April 16 at 9:00 AM
	Tilray Brands Missed on Revenue in Q3, but This Is the More Concerning Number for Investors fool.com - April 16 at 7:15 AM
	3 Cannabis Penny Stocks to Buy for 3-Bagger Returns investorplace.com - April 16 at 6:45 AM
	Tilray (NASDAQ:TLRY) Trading Up 0.8% marketbeat.com - April 15 at 3:58 PM
	3 Pot Stocks That Could Make You a Cannabis Millionaire investorplace.com - April 15 at 11:20 AM
	FY2024 Earnings Estimate for Tilray Inc Issued By Roth Capital (NASDAQ:TLRY) americanbankingnews.com - April 15 at 1:34 AM
	Tilray (NASDAQ:TLRY) Trading Down 0.5% americanbankingnews.com - April 14 at 4:36 AM
	Tilray (NASDAQ:TLRY) Shares Down 0.5% marketbeat.com - April 12 at 2:50 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Micron Technology Results Proves AI is Driving Storage Demand
March 26, 2024 7:35 AM
View Micron Technology Results Proves AI is Driving Storage Demand
Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
April 10, 2024 10:42 AM
View Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
Cannabis: One Stock to Play the Movement
April 8, 2024 8:38 AM
View Cannabis: One Stock to Play the Movement
Tilray’s Q3 Earnings Reveal Growth Despite Challenges
April 10, 2024 7:20 AM
View Tilray’s Q3 Earnings Reveal Growth Despite Challenges

All Headlines

Company Descriptions

Cronos Group

NASDAQ:CRON

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

STADA Arzneimittel Aktiengesellschaft

OTCMKTS:STDAF

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

Tilray

NASDAQ:TLRY

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial